Drug Approval | June 01, 2026
Wockhardt wins FDA nod for new antibiotic ZAYNICH against drug-resistant infections
The approval marks a major milestone in the global fight against antimicrobial resistance
The approval marks a major milestone in the global fight against antimicrobial resistance
Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.
Discussions during the meeting focused on strengthening India’s preparedness against zoonotic diseases and climate-sensitive health challenges
Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
Experts call for integrated, evidence-based approaches to tackle rising dengue, malaria, and chikungunya burden in Indian cities
His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research
Collaboration to drive diagnostics exports, tap high-growth regional markets and build scalable commercialization platform
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
